Skip to main content

Table 1 Characteristics of the study participants

From: Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate

 

Men (N = 4,075)

Women (N = 5,572)

p value*

Age (years)

49 (17)

49 (17)

0.7303

Body mass index (kg/m2)

26.5 (3.9)

25.3 (5.0)

<0.0001

Systolic blood pressure (mmHg)

131 (16)

125 (18)

<0.0001

Diastolic blood pressure (mmHg)

83 (10)

79 (10)

<0.0001

Antihypertensive drug use

715 (17.6%)

1,002 (18.0%)

0.580

Total cholesterol (mg/dL)

203 (40)

207 (38)

<0.0001

Triglycerides (mg/dL)

124 (98)

95 (54)

<0.0001

HDL-cholesterol (mg/dL)

49 (12)

58 (13)

<0.0001

LDL-cholesterol (mg/dL)

130 (36)

130 (34)

0.9400

Antilipidemic drug use

202 (5.0%)

306 (5.5%)

0.245

Fasting blood glucose (mg/dL)

100 (25)

93 (24)

<0.0001

Serum uric acid (mg/dL)

5.3 (1.3)

3.6 (1.1)

<0.0001

AST (U/L)

24 (16)

20 (11)

<0.0001

ALT (U/L)

32 (25)

21 (16)

<0.0001

White blood cells (×103/μL)

7.4 (1.8)

6.9 (1.8)

<0.0001

Red blood cells (×103/μL)

5.2 (0.6)

4.7 (0.5)

<0.0001

eGFRa (mL/min/1.73 m2)

73 (15)

69 (16)

<0.0001

Current smokers

962 (23.6%)

728 (13.1%)

<0.0001

Wine drinkers

2,343 (57.6%)

1,302 (23.4%)

<0.0001

Phisically active

585 (14.4%)

915 (9.2%)

<0.0001

  1. Data are presented as absolute and relative frequencies, no. (%), or means (SD).
  2. ALT alanine transaminase, AST aspartate transaminase, eGFR estimated glomerular filtration rate.
  3. aeGFR was calculated using the MDRD formula following the recommendations of the National Kidney Disease Education Program.
  4. p value refers to t test for difference in mean values, for quantitative variables, and to Chi square test for homogeneity of proportions, for categorical variables, between men and women.